| Trial ID: | L0700 |
| Source ID: | NCT04411862
|
| Associated Drug: |
Phosphatidylcholine
|
| Title: |
Efficacy of Phosphatidylcholine in Addition to Behavior Therapy by Clinical Pharmacist in the Management of Non Alcoholic Fatty Liver (NAFLD)
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: Phosphatidyl Choline;Behavioral: Lifestyle modification
|
| Outcome Measures: |
change from baseline Body Mass Index (BMI) at 3 and 6 month;change from baseline liver stiffness at 3 and 6 month;change from baseline Lipid Profile;change from baseline Oxidative stress markers;change from baseline NAFLD score at 3 and 6 month;change from baseline homeostasis model assessment Insulin resistance HOMA IR scores at 3 and 6 monthchange from baseline Complete Blood Picture at 3 and 6 month
|
| Sponsor/Collaborators: |
Nehal Abou Seada
|
| Gender: |
All
|
| Age: |
18 Years65 Years
|
| Phases: |
Phase 3
|
| Enrollment: |
100
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
10/05/2020
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
--
|
| URL: |
https://clinicaltrials.gov/show/NCT04411862
|
